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Alcoholism is a chronic relapsing disorder characterized by continued alcohol use despite
numerous adverse consequences. Alcohol has been shown to interact with numerous
neurotransmitter systems to exert its pharmacological effects. The endogenous opioid
system (EOS) has been strongly implicated in the positive and negative reinforcing
effects of alcohol. Traditionally recognized as dysphoric/anhedonic in nature, the
dynorphin/kappa-opioid receptor (DYN/KOR) system has recently received considerable
attention due to evidence suggesting that an upregulated DYN/KOR system may be a
critical contributor to the complex factors that result in escalated alcohol consumption
once dependent. The present review will discuss alcohol-induced plasticity in the
DYN/KOR system and how these neuroadaptations could contribute to excessive alcohol
seeking and consumption.
Keywords: alcohol, dependence, depression, dynorphin, ethanol, kappa-opioid receptor, negative affect,
withdrawal
INTRODUCTION
Alcohol use disorders, comprising alcohol abuse and dependence,
pose a substantial physical, mental, and fiscal health risk to mil-
lions of people each year in the US, causing an average of 79,000
deaths and costing $224 billion annually (Grant et al., 2004;
Bouchery et al., 2011). Alcohol exerts it’s effects through mul-
tiple neurotransmitter systems, e.g., dopamine (DA), glutamate,
γ-aminobutyric acid (GABA), and serotonin (5-HT) systems
(Colombo et al., 2004; Johnson, 2004; Walker and Ettenberg,
2007; Heinz et al., 2009). In particular, the endogenous opi-
oid system (EOS) has proven to be important when considering
the positive reinforcing effects of alcohol. Furthermore, the EOS
undergoes neuroadaptations following chronic alcohol exposure
that lay the foundation for alcohol to serve as a potent negative
reinforcer during both acute and protracted withdrawal following
chronic alcohol exposure (for a review of negative reinforcement
from a learning perspective, see Walker, 2012).
Acute alcohol stimulates the release of β-endorphin (βEND),
enkephalin (ENK), and dynorphin (DYN) (Gianoulakis et al.,
1996; Marinelli et al., 2003, 2004, 2005, 2006; Dai et al., 2005; Lam
et al., 2008; Jarjour et al., 2009). βEND and ENK, endogenous
ligands for μ-(MOR) and δ-(DOR) opioid receptors, respec-
tively, have been linked to euphoric and positive reinforcing
effects of alcohol (Stromberg et al., 1998; Hyytia and Kiianmaa,
2001). Conversely, DYN, the endogenous ligand for the κ-opioid
receptors (KORs) (Chavkin et al., 1982), has been shown to
produce aversive effects related to alcohol challenge (Lindholm
et al., 2001). There are two forms of DYN, DYN A, and DYN
B, although for the purposes of this review, they will be collec-
tively called DYN because the precise neurobehavioral differences
between the two has yet to be established. The KOR is the pref-
erential binding site for DYN (Chavkin et al., 1982; Merg et al.,
2006), although DYN has affinity for all three opioid receptors
(Merg et al., 2006; Schwarzer, 2009).
The KOR, a G-protein coupled receptor, induces inhibitory
signaling (Connor and Christie, 1999; Al-Hasani and Bruchas,
2011; but see Crain and Shen, 1990) and has been shown to
regulate the release of various neurotransmitters including DA,
glutamate, GABA, norepinephrine (NE), and 5-HT (Mulder et al.,
1984; Jackisch et al., 1986; Schoffelmeer et al., 1997; Shippenberg
and Rea, 1997; Rawls et al., 1999; Shippenberg et al., 2007; Land
et al., 2009). Details of these interactions have been reviewed
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previously (Vengeliene et al., 2008; Heinz et al., 2009). The
dynorphin/kappa-opioid receptor (DYN/KOR) system is widely
distributed in the CNS and has been implicated in numer-
ous physiological and pathophysiological conditions related to
mood and motivation (Bruijnzeel, 2009; Schwarzer, 2009; Wee
and Koob, 2010; Tejeda et al., 2012), identifying the DYN/KOR
system as a putative therapeutic target for the treatment of var-
ious neuropsychiatric disorders (Walker and Koob, 2008; Knoll
and Carlezon, 2010; Wee and Koob, 2010; Tejeda et al., 2012;
Walker et al., 2012). Also becoming apparent, is the importance of
the dysphoric/anhedonic properties of a hyperactive DYN/KOR
system in alcohol dependence that contributes to the negative
reinforcing effects of alcohol (Walker and Koob, 2008; Nealey
et al., 2011; Walker et al., 2011). The present review focuses
on alcohol-induced plasticity in the DYN/KOR system and how
these neuroadaptations perpetuate excessive alcohol seeking and
consumption.
THE DYN/KOR SYSTEM IN MOTIVATIONAL AND EMOTIONAL
NEUROCIRCUITRY
Neuropharmacological studies have identified brain regions
mediating the reinforcing effects of alcohol and other drugs
of abuse. The mesolimbocortical dopamine system [DA from
the ventral tegmental area (VTA) to the nucleus accumbens
(Acb) or prefrontal cortex (PFC)] and extended amygdala [cen-
tral nucleus of the amygdala (CeA), bed nucleus of the stria
terminalis (BNST) and Acb Shell (AcbSh)] represent neurocir-
cuitry related to motivational and cognitive decision making,
as well as emotional, neurocircuitry thought to participate in
the reinforcing effects of alcohol. Figure 1 summarizes brain
motivational and emotional neurocircuitry and illustrates sev-
eral relevant neurotransmitter systems that can be modulated by
KORs and are implicated in the pathophysiology of various psy-
chiatric disorders following exposure to drugs of abuse, including
alcohol. KORs are presynaptically positioned on dopaminer-
gic inputs to amygdala (Amyg), Acb and PFC (Werling et al.,
1988; Frankhuijzen et al., 1991; Grilli et al., 2009), GABAergic
inputs to Acb, Amyg and BNST (Hjelmstad and Fields, 2003),
serotonergic inputs to Acb (Land et al., 2009), noradrenergic
inputs to PFC (Berger et al., 2006) and glutamatergic inputs
to VTA and Acb (Hjelmstad and Fields, 2001). KORs are also
found directly on the perikarya of dorsal raphe 5-HT neu-
rons (Land et al., 2009), locus coeruleus NE neurons (Reyes
et al., 2009) and VTA mesocortical DA neurons (Margolis et al.,
2006). As such, KORs are positioned to modulate numerous neu-
rotransmitter systems implicated in neuropsychiatric disorders
FIGURE 1 | The DYN/KOR system in motivational and emotional
neurocircuitry. A schematic representation of brain motivational and
emotional neurocircuitry, illustrating relevant neurotransmitters implicated in
the pathophysiology of various neuropsychiatric disorders following chronic
exposure of alcohol and drugs of abuse. Abbreviations: PFC, prefrontal
cortex; Acb, nucleus accumbens; AMYG, amygdala; BNST, bed nucleus of
the stria terminalis; VTA, ventral tegmental area; DR, dorsal raphe; LC, Locus
coeruleus; GABA, γ-aminobutyric acid; DYN, dynorphin; cAMP, cyclic AMP,
CREB, cAMP response element-binding protein; FosB, a member of the
Fos family of transcription factors.
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within motivational and emotional circuitry (Heinz et al., 2009;
Schwarzer, 2009).
ALCOHOL-INDUCED PLASTICITY IN THE DYN/KOR SYSTEM
Understanding the acute neurobiological effects of alcohol is criti-
cally important because once known, it may be possible to predict
the neuroadaptive, and resulting, behavioral impact of long-term
alcohol exposure using theories such as the opponent-process
theory of motivation (OPT; Solomon and Corbit, 1974). If apply-
ing this theory to alcoholism, in order to maintain homeostasis,
an increase in hedonic state (e.g., alcohol-induced euphoria)
will be followed by a compensatory decrease in hedonic state
(Figure 2). Furthermore, after repeated alcohol exposure, the
positive hedonic state is reduced while the negative component
is enhanced to compensate for the continued perturbation of the
affective system by chronic alcohol exposure (Figure 2). As the
cycle continues, the cessation of alcohol intake would result in
the production of a negative affective state during withdrawal
that can drive an organism to excessively seek and use alco-
hol. In accordance with the OPT, if alcohol-mediated MOR or
DOR stimulation (Marinelli et al., 2004, 2005; Lam et al., 2008;
Jarjour et al., 2009) produces positive hedonic states (Amalric
et al., 1987; Shippenberg et al., 1987), then a compensatory
mechanism could be increased DYN and/or function of KORs,
stimulation of which produces negative hedonic states (Mucha
and Herz, 1985). Under conditions of chronic alcohol use (see
Figure 2), the predicted response of the endogenous opioider-
gic system would be attenuated MOR signaling and exacerbated
DYN/KOR system activity, both of which are supported in the lit-
erature (Gianoulakis et al., 1996; Przewlocka et al., 1997; Turchan
et al., 1999; Chen and Lawrence, 2000; Lindholm et al., 2000;
Saland et al., 2004; Lindholm et al., 2007). In addition, chronic
alcohol exposure has been shown to alter various neuropeptide
systems (e.g., corticotropin-releasing factor (CRF), neuropeptide
Y and nociceptin; Cowen and Lawrence, 2006; Ciccocioppo et al.,
2009; Koob, 2010) that may contribute to the development of
alcohol dependence and/or negative affective states. Therefore, a
“counter-regulatory” the DYN/KOR system is recruited following
exposure to alcohol and other drugs of abuse. Repeated alco-
hol exposure upregulates the DYN/KOR system and creates a
state that facilitates alcohol seeking and consumption. The pre-
cise mechanisms that underlie escalated alcohol consumption in
alcohol dependent states may involve adaptations at the pharma-
cological, transcriptional, and epigenetic levels and are discussed
below.
PHARMACOLOGICAL EVIDENCE
It has been proposed that the neuroadaptive changes that occur in
response to chronic alcohol use can occur via within- or between-
system changes in reward and anti-reward systems, respectively
(Koob and Bloom, 1988; Koob and Le, 2008; Koob, 2009). There
is evidence supporting both possibilities in the form of neu-
roadaptations that occur within classical motivational systems
(Koob and Weiss, 1992; McBride and Li, 1998; Siggins et al.,
2003; Koob, 2004; Funk and Dohrman, 2007), as well as sys-
tems distinct from those that are involved in anhedonia and
dysphoria (Valdez et al., 2002; Funk et al., 2006; Walker and
Koob, 2008; Sperling et al., 2010; Nealey et al., 2011; Walker
et al., 2011). Although DA and the EOS within the mesolimbic
pathway, ventral striatum and CeA participate in dependence-
induced within-system changes and stress-related peptides in the
extended amygdala are hypothesized to participate in between-
system changes [see the excellent review, (Koob, 2009)], there are
several other neuropeptides involved in the positive and nega-
tive reinforcing effects of alcohol (Cowen and Lawrence, 2006;
Koob and Le, 2008; Ciccocioppo et al., 2009; Gilpin and Roberto,
2012) that show great promise as therapeutics for the treatment
of certain aspects of addictive disorders. Strong support for the
OPT is recent evidence demonstrating that acute alcohol admin-
istration initially increases βEND within the first 30min that
is followed by a significant increase in DYN A approximately
1.5–2 h later (Lam et al., 2008; Jarjour et al., 2009); a profile
that is also observed within the Acb and VTA (Marinelli et al.,
2004, 2006; Jarjour et al., 2009). The OPT predicts that chronic
alcohol exposure would decrease positive affect and increase
negative affect (see Figure 2). In support of that prediction, evi-
dence has shown that the MOR– and DOR–regulated component
of the opioid system shows decreased signaling in response to
chronic alcohol (Turchan et al., 1999; Chen and Lawrence, 2000;
Saland et al., 2004). Also consistent with that hypothesis, chronic
FIGURE 2 | Alcohol dependence-induced change in opioidergic system.
In non-dependent organisms, alcohol-induced positive affective states
mediated by the μ-opioid receptor precede compensatory negative
affective states expressed through the κ-opioid receptor. Following chronic
alcohol exposure, μ-opioid receptor signaling is attenuated and through
multiple mechanisms, κ-opioid receptor signaling is increased to
produce increased negative affective states. Adapted from Walker et al.
(2012).
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alcohol–exposed animals have been shown to have increased pro-
dynorphin mRNA levels in the Acb (Przewlocka et al., 1997),
increased expression of DYN B in the Acb (Lindholm et al., 2000)
and altered KOR mRNA expression in the Acb and VTA (Rosin
et al., 1999) that support the concept of an upregulated DYN/KOR
system in these areas.
The functional impact of increased DYN/KOR system activ-
ity in dependence involves, in part, the mesolimbocortical DA
system. This system has been implicated as a signaling system
for biologically relevant information through which drugs of
abuse (Koob, 2000; Maldonado, 2003; Di et al., 2004) and nat-
ural reinforcers (Hull et al., 1999; Carelli, 2002; Kelley et al.,
2002, 2005) or punishers can exert their behavioral effects due
to the mesolimbic DA pathway’s capacity for bidirectional sig-
naling (i.e., ability to signal both positive and negative stimuli;
Wheeler and Carelli, 2009). Within the mesolimbic DA system,
KORs are neuroanatomically positioned on DA terminals in the
AcbSh that enables them to oppose the effects of MOR ago-
nists on DA release (Di and Imperato, 1988). KORs are also
positioned on DA perikarya in the VTA (Margolis et al., 2003,
2006). Much research has been done to determine how KOR
stimulation impacts dopaminergic neurotransmission and drug
self-administration, (for an excellent review, see Shippenberg
et al., 2007). In essence, while the KORs positioned on the ter-
minal regions in the AcbSh reduce DA release (Di and Imperato,
1988) in that region, KORs on VTA DA neurons do not (Spanagel
et al., 1992; Margolis et al., 2006), but instead selectively reduce
DA release in the PFC (Margolis et al., 2006). Thus, increased
signaling through DYN/KOR system could functionally result in
an attenuated dopaminergic system in both cortical and limbic
circuitry. Indeed, deficiencies in dopaminergic transmission have
been posited by some to be the neurobiological basis of depression
(Nestler and Carlezon, Jr., 2006).
Substantial evidence supports the concept of chronic alcohol–
induced attenuation of DA (Carroll et al., 2006; Healey et al.,
2008). Stimulation of KORs produces dysphoria in humans
(Pfeiffer et al., 1986) and place aversions in animals (Mucha
and Herz, 1985). Furthermore, increased DYN transmission in
the Acb has been hypothesized to induce depressive–like behav-
ioral states in animal models of depression and negative affect
(Pliakas et al., 2001; Mague et al., 2003; Carlezon, Jr. et al.,
2006). The DYN/KOR system in the basolateral amygdala (BLA)
has been implicated as a mediator of dysphoria through which
stress–related systems can exert their effects (Land et al., 2008).
Thus, if a compensatory response to chronic alcohol involved
alterations in DYN/KOR signaling, then DYN/KOR–mediated
negative affect could contribute to the increased alcohol con-
sumption observed in dependence. Taken together, increased
DYN transmission could result in attenuated dopaminergic trans-
mission and produce depressive–like behaviors and dysphoria
that are thought to involve multiple nuclei within extended Amyg
circuitry. Therefore, if the DYN/KOR system is upregulated fol-
lowing chronic alcohol exposure in a manner sufficient to pro-
duce escalated alcohol self-administration (Roberts et al., 2000;
O’Dell et al., 2004; Walker and Koob, 2008), KOR antagonists
should be able to reduce negative affective states associated with
withdrawal and reduce the excessive alcohol self-administration.
Recent studies substantiating this hypothesis demonstrated that
systemic, intracerebroventricular and intra-AcbSh administration
of a KOR antagonist were able to selectively reduce escalated
operant self-administration of alcohol in dependent Wistar rats
while leaving nondependent alcohol self-administration intact
(Walker and Koob, 2008; Nealey et al., 2011; Walker et al., 2011).
These selective effects of KOR antagonists in dependent animals
strongly implicate the recruitment of DYN/KOR system during
the transition to alcohol dependence.
Although considerable work has focused on KOR modula-
tion of DA transmission, KORs within the extended amygdala
can presynaptically modulate other neurotransmitters (e.g., glu-
tamate, GABA and serotonin; Fields et al., 2007; Land et al.,
2009; Li et al., 2012). As many of these neurotransmitter systems
have been implicated in alcohol reinforcement and dependence,
upregulated DYN/KOR activity could be a common mechanism
that adversely impacts motivational and emotional neurocir-
cuitry. Specifically, KORs can presynaptically inhibit GABAergic
signaling in the BNST that is thought to remove an important
inhibitory influence on glutamatergic neurons and could con-
tribute to the hyperglutamatergic state observed during alcohol
withdrawal (Spanagel, 2009; Li et al., 2012). Furthermore, sero-
tonergic projections from the dorsal raphe to limbic brain regions
(Hensler, 2006) that can regulate affect and drug seeking behavior
(Land et al., 2009; Bruchas et al., 2011) are impacted by alco-
hol exposure (Chu and Keenan, 1987; Pistis et al., 1997) and
may be dysregulated during alcohol dependence (Gorwood et al.,
2000; Shibasaki et al., 2010). KORs can also impact 5-HT lev-
els via modification of efflux/tone (Tao and Auerbach, 2005) and
appear to mediate aversive behavior in mice (Land et al., 2009).
A recent study suggested that KOR mediated p38 MAPK signal-
ing can induce serotonin transporter (SERT) translocation from
the intracellular pool to the neuronalmembrane, thereby enhanc-
ing serotonin reuptake (Land et al., 2009; Bruchas et al., 2011)
and causing a hyposerotonergic state. Furthermore, Shibasaki
and colleagues have shown upregulated SERT mRNA in the dor-
sal raphe of alcohol-dependent rodents (Shibasaki et al., 2010).
Taken together, DYN/KORs in this circuitry may be upregu-
lated in alcohol dependence and may reduce serotonergic tone
through a p38 MAPK-dependent SERT translocation mechanism
that can contribute to the development of a negative affective
state. Modulation of this state has been shown to manage cer-
tain symptoms of rapid alcohol exposure (Johnson, 2004; Uzbay,
2008), although the face and predictive validity of themodels used
to evaluate alcohol withdrawal should be carefully scrutinized.
Another mechanism through which KORs can regulate affect was
identified by Hjelmstad and Fields (2001) who documented that
KORs are also anatomically positioned on presynaptic terminals
of glutamatergic inputs from the PFC, Amyg and hippocampus to
the Acb. Therefore, in addition to local blockade of DA release in
the Acb by DYN/KOR, KOR modulation of glutamatergic inputs
to the Acb may also be involved with aversive behaviors; how-
ever, additional studies are needed to confirm this. These studies
may help to explain the significant comorbidity between alcohol
use disorders and affective disorders (Regier et al., 1990; Grant
and Harford, 1995) that can plague those afflicted with alcohol
dependence.
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The EOS may also have a role in certain cognitive processes
relevant for control of addictive behavior including craving,
decision-making and impulsivity (O’Malley et al., 2002; Bencherif
et al., 2004; Boettiger et al., 2009; Love et al., 2009). Thus, a
dysregulated EOS may contribute to impaired neurocognitive
function and reduced regulation of alcohol/drug seeking and con-
sumption. A recent study demonstrated a significant increase
in PDYN mRNA (PDYN is the precursor peptide for the two
forms of DYN, DYN A, and DYN B) in the dorsolateral pre-
frontal cortex (dl-PFC), and KOR mRNA in the orbitofrontal
cortex (OFC) of deceased alcoholics when compared to controls
(Bazov et al., 2011; Taqi et al., 2011b). Furthermore, levels of
both DYN A and DYN B were significantly elevated in the dl-
PFC and hippocampus of alcoholics. Importantly, the levels of
PDYN mRNA significantly correlated with those of DYN pep-
tides. These alterations were observed in brain regions involved
in cognitive control of addictive behavior. Therefore, DYNs may
have a role in regulation of executive functions and their elevation
may impair these cognitive processes. In addition, DYN A can
induce effects that are not blocked by opioid antagonists (Faden
and Jacobs, 1983; Dubner and Ruda, 1992; Caudle and Mannes,
2000; Lai et al., 2001; Tan-No et al., 2001, 2005; Singh et al., 2003;
Hauser et al., 2005). These non-canonical non-opioid effects, gen-
erally excitatory, may lead to neurodegeneration and pathological
behavior such as chronic pain and paralysis. Therefore, both
the opioid-receptor mediated and non-opioid neurodegenerative
mechanisms may underlie the behavioral effects of upregulated
DYN/KOR system in alcoholics.
TRANSCRIPTIONAL EVIDENCE
Following DA release in motivational nuclei (i.e., Acb), it binds
to its receptors (D1- or D2-like) and produces excitatory or
inhibitory post-synaptic potentials, respectively. D1-like recep-
tor activation increases adenylyl cyclase activity by coupling to
stimulatory G proteins (Gαs). This leads to an increase in the
concentration of cyclic AMP (cAMP) and potentiation of cAMP-
dependent protein kinases A (PKA) activity that further phospho-
rylates downstream signaling substrates. One signaling substrate
is the transcription factor cAMP response element-binding pro-
tein (CREB) that activates the transcription of PDYN, BDNF,
CRF, NPY, and other genes (Lonze and Ginty, 2002; Carlezon,
Jr. et al., 2005). CREB-mediated increases in DYN within the
Acb serves as a negative feedback circuit whereby it decreases DA
release in Acb through presynaptic receptors on DA containing
nerve terminals (see Figure 1). This is evident from experiments
showing that KOR antagonist blocks the effects of CREB over-
expression (Carlezon, Jr. et al., 1998). Because alcohol exposure
may alter CREBmediated pathway in the Acb (Misra et al., 2001),
mice lacking a regulatory subunit of PKA show attenuated cAMP-
PKA signaling in the Acb and increased alcohol consumption
(Thiele et al., 2000). In addition, PKA inhibition, that further
decreases PKA/CREB activity, produces high alcohol preference in
rodents (Misra and Pandey, 2006). Activation of CREB results in
elevation of DYN levels in this circuitry (Carlezon, Jr. et al., 1998).
Upregulated CREB signaling in the VTA-Acb pathway produces
pro-depressive behavior (Pliakas et al., 2001; Malberg and Blendy,
2005), while CREB or DYN inhibition in the Acb produces an
antidepressant-like effect (Newton et al., 2002). Early exposure
to methylphenidate that causes sustained elevation in CREB in
Acb produces anhedonia and dysphoria (Bolanos et al., 2003;
Carlezon, Jr. et al., 2003). Collectively, CREB-mediated DYN
upregulation in the Acb may mediate reduced reward and pro-
depressive effects of chronic alcohol and drug exposure. In the
Amyg, alterations in CREB-mediated signaling following alcohol
exposure has been implicated in anxiety associated with alco-
hol withdrawal, albeit in a direction opposite of that in the Acb
(Pandey et al., 2005); however, the time-points of CREB eval-
uation in the Amyg (although during acute withdrawal) were
more protracted than in other investigations (24 h vs. 6–10 h into
withdrawal; (Pandey et al., 2005; Williams et al., 2012, respec-
tively). Thus, CREB-mediated increases in DYN within critical
brain regions implicated in mood regulation may contribute to
the development of negative affective behavior during withdrawal
in dependent organisms.
The cAMP signaling pathway is onemechanism by which alco-
hol and other drugs of abuse can alter DYN concentrations in the
Acb via CREB-mediated transcriptional activation. In addition to
directly targeting the prodynorphin gene, CREBmay regulate sev-
eral signaling pathways (Carlezon, Jr. et al., 2005) that may acti-
vate the DYN/KOR system following chronic exposure to alcohol
or addictive drugs (Carlezon, Jr. et al., 2005; Nestler and Carlezon,
Jr., 2006). Brain- derived neurotropic factor (BDNF) is an impor-
tant CREB target (Lonze and Ginty, 2002) that modulates DYN
expression in brain region specific manner (Nair and Vaidya,
2006). BDNF, a member of the nerve growth factor (NGF) fam-
ily, and its receptor TrkB are widely distributed throughout the
brain (Wetmore et al., 1990; Altar et al., 1994), and have a role in
synaptic plasticity (Chao, 2003) associated with alcohol addiction
(Uhl et al., 2001) and several psychiatric disorders (Martinowich
et al., 2007). BDNF expression is associated with early onset of
alcoholism (Matsushita et al., 2004). Alcohol exposure increases
BDNF expression in the dorsal striatum (DS) leading to pro-
dynorphin activation (Logrip et al., 2008). These effects are brain
region specific (Nair and Vaidya, 2006) and further work is
needed to understand the precise pathophysiological mechanisms
of dysregulated CREB-BDNF signaling in alcohol dependence.
Thus, alcohol and other substances of abuse may dysregulate
CREB-mediated signaling in the Acb leading to DYN upregula-
tion. That upregulation appears to contribute to the depressive
and aversive effects of alcohol, cocaine and other illicit drugs
(Carlezon, Jr. et al., 1998, 2005; McClung and Nestler, 2008).
One transcription factor that gained attention for its puta-
tive role in long-lasting plastic changes underlying addiction is
FosB (Nestler et al., 2001). FosB is a member of the Fos
family of transcription factors encoded by the FOS genes. Fos
proteins are rapidly, but for a short period of time, induced in
Acb and dorsal striatum, brain regions involved in the reward-
ing and locomotor effects of various drugs of abuse and alcohol
(Nye and Nestler, 1996; Kelz et al., 1999; Kelz and Nestler, 2000;
Perrotti et al., 2008). Following chronic treatment with alcohol
or drugs of abuse only FosB has been found to accumu-
late in many brain regions related to goal-directed actions and
decision-making, including the striatum and PFC (Hope et al.,
1994; Kelz and Nestler, 2000; Perrotti et al., 2008). FosB is an
unusually stable, C-terminally truncated variant of the immedi-
ate early gene product FosB. FosB is thought to function as a
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sustained molecular switch for addiction. Chronic exposure of
rodents to most drugs of abuse, including cocaine, morphine,
9-tetrahydrocannabinol, and alcohol, causesFosB to accumu-
late in addiction-related circuitry (Perrotti et al., 2008), wherein
it has been suggested to regulate the expression of several genes
commonly associated with this disease (Nestler, 2008; Robison
and Nestler, 2011). FosB regulates gene expression via forma-
tion of the AP-1 complex that is critically involved in regulation
of neuronal activity and behavior after long period of with-
drawal (Nestler et al., 2001). FosB may be selectively induced
in DYN/substance P containing neurons (Moratalla et al., 1996).
Expression of several genes, including PDYN, may be regulated by
FosB. It has been hypothesized that FosB-mediated suppres-
sion of DYN expression in Acb may increase the sensitivity for
the rewarding effects of drugs of abuse (Zachariou et al., 2006).
These effects may oppose CREB-mediated signaling andFosB is
thought to be involved in maintaining addiction-related changes
in neurophysiology by: (1) enhancing the rewarding and incentive
motivational properties of drugs of abuse via its actions in the Acb
and (2) producing tolerance to the cognitive-disrupting effects of
such drugs via its actions in the PFC. Relatively short-lived CREB-
DYN activity and persistent FosB effects might explain some
CREB-DYN mediated behaviors (e.g., tolerance, negative affec-
tive states, and depression-like behavior) during early stages of
alcohol withdrawal. Alternatively, FosB/DYN-mediated effects
may be important during later stages of abstinence from alcohol
or drug of abuse (Nestler et al., 2001).
Transcriptional models of addiction involving CREB and
FosB gained support in pharmacological and genetic experi-
ments with rodents. However, the promoter and enhancer struc-
ture of many human and rodent genes that are implicated in
addictive behavior (including PDYN) are not completely con-
served across species. To address the FosB hypothesis in the
context of substance dependence in humans, FosB proteins in
human brain were characterized by analysis of postmortem spec-
imens, and compared their levels in the OFC and dlPFC, respec-
tively between human controls and alcoholics (Watanabe et al.,
2009). These two sub-regions of the larger PFC are important
nuclei within addiction neurocircuitry and chronic exposure to
alcohol or other drugs of abuse has been shown to result in accu-
mulation of FosB in both structures (Winstanley et al., 2007;
Perrotti et al., 2008). In both the dl-PFC andOFC, as well as in the
Acb, three forms of FosB were detected, one of which wasFosB.
The later protein was found to be expressed at very low, barely
detectable levels in all three human brain regions. Importantly no
differences in FosB levels were evident between alcoholics and
control groups. These human results do not support the FosB
hypothesis; they indicate that FosB does not accumulate in the
OFC and dlPFC of human alcoholics, suggesting that it may not
be directly involved in addiction maintenance, at least not in
alcohol dependence.
AP-1 may potentially regulate transcription of human
prodynorphin gene in the human brain. Analysis of AP-1
constituents in the human brain demonstrated that canonical
and noncanonical prodynorphin AP-1-binding element may be
targeted by c-Jun and FosB proteins that form the dominant AP-
1 complex (Taqi et al., 2011a). No FosB was found in such
a complex. Nonetheless, transcription of human PDYN may be
regulated by AP-1 forming JunD/FosB heterodimers that binds to
a noncanonical AP-1-binding element. This element has a poly-
morphic site with the T allele conferring AP-1 binding. The C
allele of this single nucleotide polymorphism (SNP; rs1997794)
that destroys this site represents the allele that is associated with
alcohol dependence. Thus, a SNP in the promoter of PDYN
is associated with alcohol-dependence and may impact PDYN
transcription in human brain. The impact of genetic variations
on PDYN transcription may be relevant for diverse adaptive
responses of this gene to alcohol.
EPIGENETIC EVIDENCE
Pleasurable and adverse states resulting from the intake of alcohol
and addictive drugs can shape individual differences in the vul-
nerability to addictive disorders. A fundamental question is how
these experiences are encoded at a molecular level in a man-
ner that leads to long-term alterations in plasticity that underlie
increased risk for substance abuse. Dysregulation of epigenetic
mechanisms could lead to silencing or inappropriate expression
of specific genes that could contribute to the pathologies observed
in those who are alcohol dependent.
Epigenetics is typically defined as the study of heritable
changes in gene expression that are not due to changes in DNA
sequence (Eccleston et al., 2007). Hence, identical DNA sequences
with differential epigenetic regulation could result in differential
gene expression. Epigenetic regulation seems to be time and tis-
sue specific and can be quite diverse even within the same tissue
or individual. Epigenetic changes represent alterations in gene
expression that are self-perpetuating in the absence of the original
signal that caused them (Berger et al., 2009). Environmental fac-
tors, including alcohol, can modulate gene expression by induc-
ing alterations in epigenetic markers such as DNA methylation
and histone modifications. Epigenetic changes have been asso-
ciated with a range of neurobiological processes including brain
development, synaptic plasticity, learning and memory and neu-
ropathologies such as drug addiction (Borrelli et al., 2008; Renthal
and Nestler, 2008; Roth and Sweatt, 2009). DNA methylation
is the most stable epigenetic mark that is responsive to envi-
ronmental stimuli. Environmental conditions can evoke changes
in DNA methylation underlying epigenetic re-programming of
genes involved in the regulation of addictive disorders. Effects
of genetic variations including single nucleotide polymorphisms
(SNPs) on DNA methylation may depend on DNA context
(Kerkel et al., 2008; Xie et al., 2009; Hellman and Chess, 2010;
Shoemaker et al., 2010; Zhang et al., 2010). Importantly, polymor-
phic positions are most abundant at the CpG dinucleotides that
are targets for DNA methylation (Tomso and Bell, 2003; Kerkel
et al., 2008; Xie et al., 2009; Hellman and Chess, 2010; Shoemaker
et al., 2010; Zhang et al., 2010).
The Bakalkin group has recently addressed the specific hypoth-
esis that genetic, epigenetic and environmental factors associated
with a risk for addictive disorders mechanistically converge on
SNPs that (1) are associated with addiction, and (2) that overlap
with CpG sites thus representing methylation-associated SNPs, or
mSNPs (Figure 3) (Taqi et al., 2011b). The two epialleles formed
by the unmethylated and methylated C allele at such mSNPs may
differentially contribute to disease predisposition, as they may
be targeted by transcription factors or by insulator proteins that
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FIGURE 3 | General model for the integration of genetic, epigenetic
and environmental factors on vulnerability to develop addictive
disorders.Mechanistically, the effects of these factors may be
integrated through methylation of CpGs overlapping with SNPs
(mSNPs) associated with a disease. In the CpG context, the C, one of
the two genetic alleles may be methylated and function as two
epialleles, the C and 5Me-C, that may differentially affect gene
expression.
control the interactions among genomic regulatory elements (for
insulators, see (Wallace and Felsenfeld, 2007). This hypothesis (1)
unifies the genetic and epigenetic views on the vulnerability to
develop addictive disorders, and (2) may explain a part of “miss-
ing heritability” not detected in the genome-wide association
studies (GWAS).
Our analysis of PDYN regulation in the brains of deceased
human alcoholics (Taqi et al., 2011b) demonstrated that three
PDYN SNPs significantly associated with alcohol dependence
form CpG sites, and that methylation of one of them was
increased and positively correlated with DYN in alcoholics. The
mSNP hypothesis has also received support in several recent
studies (John et al., 2011; Kaminsky et al., 2012; Martin-Trujillo
et al., 2011; Reynard et al., 2011; Ursini et al., 2011). Thus, under
influences of the environment—heavy alcohol drinking-induced
alterations in methylation of this SNP may affect PDYN tran-
scription and, consequently, the vulnerability to develop alcohol
dependence. These alterations were observed in brain regions
involved in cognitive control of decision-making and may rep-
resent molecular adaptations that developed after many years of
alcohol exposure and withdrawal. DYN may have a role in the
regulation of executive and intellectual functions, learning and
memory, and emotions in alcoholics; therefore, their elevation
may impair these cognitive processes. Taken together, the results
suggest that epigenetic plasticity in the DYN/KOR system may be
involved in mediating some of the behavioral effects produced
following chronic alcohol exposure.
CONCLUSION
The goal of this review is to discuss alcohol-induced plastic-
ity in the DYN/KOR system and how these neuroadaptations
may contribute to the pathophysiology of alcohol dependence.
The DYN/KOR system has been implicated as an endogenous
anti-reward system. However, an upregulated DYN/KOR system
in various key brain regions at proximal (DYN/KOR mRNA
and expression) and intermediate (CREB/FosB/BDNF medi-
ated signaling) levels could contribute to altered distal events
(escalated alcohol use, affective/anxiety like behaviors, sensiti-
zation following abstinence) in alcohol dependence. Therefore,
increased DYN/KOR activity may induce a negative affective state
in withdrawal and provide a basis for the negative reinforcing
effects of alcohol. DYN/KORs in the Acb, Amyg and PFC/OFC
may mediate the effects of chronic alcohol exposure in a brain
region specificmanner todecrease positive hedonic states, increase
negative affective states or impair decision making and cognitive
control, respectively. In addition, epigenetic mechanisms may
also be involved in the upregulation of the DYN/KOR system
following chronic alcohol exposure. Recent data supporting the
role of the DYN/KOR system in mediating negative affective
states also help to explain significant co-morbidity between alco-
hol use disorders and affective disorders. Taken together, the
DYN/KOR system is heavily dysregulated in alcohol dependence
and represents apotential therapeutic target to combat alcoholism.
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